NCT01947153View on ClinicalTrials.gov

Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Healthy
Interventions
DRUG

Metformin

Free combination

DRUG

Linagliptin

Fixed dose combination

DRUG

Metformin

Combination

DRUG

Linagliptin

Free combination

Trial Locations (1)

Unknown

1288.21.1 Boehringer Ingelheim Investigational Site, Saint Petersburg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01947153 - Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®. | Biotech Hunter | Biotech Hunter